Moreover, deletion of DNMT3a at an early stage of effector differentiation inhibited methylation of naive-associated genes and induced re-expression of these naive genes and the resultant memory cell development (22), which may induce potent anti-cancer responses in adoptive cell therapy (9). This evidence concerns the gene DNMT3A and cancer.